A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT05429970
- Status
- Recruiting
Conditions
- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Ovarian Cancer
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
- Stage II Fallopian Tube Cancer
- Stage II Ovarian Cancer
- Stage II Ovary Cancer
- Stage III Fallopian Tube Cancer
- Stage III Ovarian Cancer
- Stage III Ovary Cancer
- Stage IV Fallopian Tube Cancer
- Stage IV Ovarian Cancer
- Stage IV Ovary Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Mind-body resilience training — BEHAVIORALMBRT is a meditation technique used to achieve relaxation)
- Music therapy — BEHAVIORALMusic listening was found, in multiple trials, to significantly reduce self-reported anxiety, physiologic indicators of anxiety, and/or sedation requirements
- Propranolol — DRUGPropranolol 20 mg PO BID (for 21 consecutive days), Propranolol 10mg PO BID (for 3 consecutive days POD 14-16)
- Etodolac — DRUGEtodolac 400 mg PO BID (for 21 consecutive days)
Study Details
The purpose of this study is to see if propranolol and etodolac along with mind-body resilience training/MBRT and music therapy help participants who are experiencing physiological stress before, during, and after primary debulking surgery/PDS or IDS and also if it's better than the standard-of-care approach (no intervention for reducing stress).
Key Dates
- Start date
- Jun 17, 2022
- Status verified
- May 2026
- Primary completion
- Jun 17, 2026
- Completion
- Jun 17, 2026
Study Design
- Enrollment
- 35 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: PSRBParticipants will receive mind-body resilience training/MBRT, music therapy, propranolol and etodolac pre and post operatively. Postoperative Psychological Interventions may occur between POD 1-7 if needed.
- No Intervention: Standard of CareParticipants will receive usual care (study interventions not specifically recommended)
Primary Outcome Measure
Number of participants successfully completing over 80% of the bundled interventions [ Time Frame: 21 days after surgical procedure ]
Central Contacts
- Kara Long Roche, MD212-639-7043
- Anoushka Afonso, MD212-639-8113
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Kara Long Roche, MD 646-608-3787 |
| Memorial Sloan Kettering Monmouth (Limited protocol activities) | Middletown | New Jersey | 07748 | Kara Long Roche, MD 646-608-3787 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Kara Long Roche, MD 646-608-3787 |
| Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) | Commack | New York | 11725 | Kara Long Roche, MD 646-608-3787 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Kara Long Roche, MD 646-608-3787 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | Kara Long Roche, MD 646-608-3787 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | Kara Long Roche, MD 646-608-3787 |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited protocol activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY
Related Studies
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruiting · M.D. Anderson Cancer Center · Miami, Florida
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerRecruiting · NRG Oncology · Birmingham, Alabama